A higher level of phosphorylated STAT3 (active STAT3) contributed to epithelial-to-mesenchymal transition (EMT) as well as increased CSC-like phenotypes of non-small cell lung cancer cells (NSCLCs), while the inhibition of STAT3 caused the opposite effects [13]. Here, STAT3 is linked to non-small cell lung carcinoma.